Company intelligence / Profile preview

Sanobiotec

Vilnius, Lithuania

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Sanobiotec is a Lithuania-based biotechnology company specializing in the research, development, and manufacturing of rare cannabinoids. The company utilizes advanced chemical synthesis and biocatalysis to produce high-purity cannabinoid compounds for the pharmaceutical, wellness, and cosmetic industries. Sanobiotec focuses on unlocking the therapeutic potential of minor cannabinoids such as CBG, CBC, and THCV through rigorous R&D and GMP-compliant production. Their services include custom synthesis, formulation development, and analytical testing, positioning them as a key CDMO partner in the global cannabinoid market.

Therapeutic areas: ImmunologyNeurologyDermatology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Sanobiotec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanobiotec.

Explore the full profile